TCL Archive In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List February 7, 1992
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick. November 14, 2008
TCL Archive In Brief: Julie Vose Was Elected President of the American Society of Clinical Oncology January 3, 2014
TCL Archive In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads February 21, 1986
TCL Archive NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines November 26, 1993
